Health Editor’s Note: Prostate cancer is one of the most common types of cancer in men. Factors that increase your risk for prostate cancer are age, family history, obesity, and being African-America. African-Americans carry a greater risk than any other race and cancers are likely to be more advanced or aggressive.
Information from John Hopkins reports: “African-American men have considerably higher incidence rates (236 cases per 100,000 in 2005 to 2009) than white men (146.9 cases per 100,000 in 2005 to 2009). African-American men may have the highest rate of prostate cancer incidence in the world. In addition, their prostate cancer mortality rate is more than twice as high as the rate for white Americans. In the period from 2005 to 2009, mortality rates were 21.7 cases per 100,000 white men compared to 53.1 cases per 100,000 African-American men. Five-year relative survival rates are lower for African-American men (96.2 percent during 2002 to 2008) than for white men (99.6 percent during 2002 to 2008). The causes of higher rates of prostate cancer among African-American males are largely unknown. Some studies have found that even when income and education are controlled for, African-Americans have much higher rates than whites. Further studies are examining the impact of a wide variety of potential risk factors, including dietary and other lifestyle differences, occupational exposures, and hormonal and genetic differences.”
Certainly there is a great need to look at why prostate cancer can be so aggressive in African-American males and this donation will enable researchers to continue to investigate this insidious medical issue and to further help veterans……Carol
$2.5 Million Gift from Robert Frederick Smith to the Prostate Cancer Foundation is the Largest Donation Ever Dedicated to Advancing Prostate Cancer Research in African-American Men
Establishes New Precision Oncology Center of Excellence (COE) Serving U.S. Veterans, and Honors the Spirit of Dr. Martin Luther King Jr.’s Legacy
SANTA MONICA, Calif., January 14, 2018 – Helping to advance revolutionary research in prostate cancer, Robert F. Smith, Founder, Chairman and CEO of Vista Equity Partners, has donated $2.5 million to the Prostate Cancer Foundation (PCF) to focus research on African-American men as well as launch The Robert Frederick Smith Center of Precision Oncology Excellence in Chicago, Illinois – to aid veterans in the metropolitan area and beyond – who are battling prostate cancer. The Smith Center will serve as a precision oncology hub in PCF’s preeminent network of centers working to fulfill the ambitious mission of improving the care of U.S. veterans with prostate cancer.
Smith’s gift is the largest donation ever made specifically targeting research and care for African-American men with prostate cancer who, statistically, are 73 percent more likely to develop prostate cancer than any other race or ethnicity.
“I am delighted to support the lifesaving work of accelerating promising medical research to serve our nation’s veterans who urgently need better treatments and cures and access to cutting-edge precision oncology,” said Robert F. Smith. “On the day we remember the life of Dr. Martin Luther King Jr., let us also remember his messages of service and of equality. With these resources, we will do right by those brave veterans who served our country, and we will change the odds for millions of African-American men who should be surviving prostate cancer.”
One in eight men will be diagnosed with prostate cancer. It is the most frequently diagnosed cancer among veterans, accounting for a third of all male cancer cases. African-American men are 2.3 times more likely to die from the disease. To date, little is known about the biological reasons for the alarming disparities.
“We are profoundly grateful to Robert F. Smith for his incredible generosity and his leadership,” said Jonathan W. Simons, MD, PCF’s president and CEO. “The Smith Center of Excellence represents a new model of American philanthropy and will pave the way for groundbreaking discoveries that will have a transformative impact on our research enterprise and its role in improving health equity for veterans and their families. These survival disparities represent a real crisis, and this gift – so timely in the spirit of honoring the legacy of Dr. King – has the power to save lives.”
The timing of Mr. Smith’s philanthropy is crucial. For veterans with late-stage disease who are running out of choices, this gift will enable the Prostate Cancer Foundation to accelerate the work of clinical investigators working to solve some of the most lethal forms of prostate cancer while also advancing the quality of healthcare for African-American men.
In 2018, PCF will fund a series of precision medicine teams at leading Veterans Administration medical centers and universities across the country through a call for proposals issued in January. Although all highly innovative research proposals will be considered, priority will be given to higher risk-highest potential of impact to maximize the benefits to veterans, with a focus on African-Americans, in the near term.
The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $745 million and provided funding to more than 2,000 research programs at nearly 200 cancer centers and universities.
The PCF global research enterprise now extends to 19 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer. For more information, visit www.PCF.org.